देश: स्पेन
भाषा: अंग्रेज़ी
स्रोत: HMA (Heads of Medicines Agencies)
cimetidine 50 mg
Intervet Intenational BV
QA02BA01
Tablet
cimetidine
Dogs Non Food
2011-04-29
I.B. SUMMARY OF PRODUCT CHARACTERISTICS, LABEL AND PACKAGE LEAFLET I.B.1. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Zitac vet 50 mg tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: cimetidine 50 mg per tablet. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. Oblong tablets, scored on both sides. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Symptomatic treatment for the reduction of vomiting associated with chronic gastritis in dogs. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Treatment with cimetidine is symptomatic only and does not result in resolution of histopathological changes associated with gastritis. It is recommended that dogs showing persistent vomiting should undergo appropriate investigations to diagnose the underlying cause before starting treatment. This is especially important in older animals. The reduction of gastric acidity caused by cimetidine may contribute to bacterial overgrowth and antigenic stimulation. 4.5 SPECIAL PRECAUTIONS FOR USE i) Special precautions for use in animals In case of renal dysfunction, adjustment of the dose may be required as the clearance of cimetidine may be decreased. If the response to treatment is poor within 15 days, the diagnosis and treatment plan should be re-evaluated. ii) Special precautions to be taken by the person administering the medicinal product to animals None. पूरा दस्तावेज़ पढ़ें